Filing Details

Accession Number:
0001140361-17-037138
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-02 17:01:01
Reporting Period:
2017-09-29
Accepted Time:
2017-10-02 17:01:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1260990 Gtx Inc GTXI Pharmaceutical Preparations (2834) 621715807
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1602393 Foundation Peak Pyramid 1350 Concourse Avenue
Suite 383
Memphis TN 38104
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-29 565,291 $0.00 4,390,243 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2017-09-29 339,174 $0.00 339,174 $9.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
339,174 No 4 P Direct
Footnotes
  1. The reported securities are included within 565,291 immediately separable units (each, a "Unit"). The purchase price per Unit was $8.845. Each Unit consists of one share of common stock of the registrant and a warrant to purchase 0.6 of a share of common stock of the registrant.
  2. The warrants will be exercisable at any time and from time to time on or after September 29, 2017 and through and including September 29, 2022, at an exercise price of $9.02 per share subject to adjustment from time to time.